Session Details

[P-HP]Hepatitis

Thu. Oct 31, 2019 9:00 AM - 12:00 PM JST
Thu. Oct 31, 2019 12:00 AM - 3:00 AM UTC
Poster Room Exhibition Hall
Viewing

[P-HP-01]Epidemiological and genetic analysis of a 2018 outbreak of hepatitis A in Japan

*Ryuichi Sugiyama1, Tomimasa Sunagawa2, Tomoko Kiyohara1, Ryosuke Suzuki1, Koji Ishii3, Masamichi Muramatsu1 (1. Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan, 2. Infectious Disease Surveillance Center, National institute of Infectious Diseases, Tokyo, Japan, 3. Department of Quality Assurance and Radiological Protection, National Institute of Infectious Diseases, Tokyo, Japan)

[P-HP-02]Phylogenetic analysis of rare genotype of hepatitis A virus detected in febrile patients in Gabon

Haruka ABE1, Yuri Ushijima1, *Rodrigue Bikangui2,3, Marguerite M. Loembe2,3,4, Selidji T. Agnandji2,3, Bertrand Lell2,3,5, Jiro Yasuda1,6,7 (1. Institute of Tropical Medicine, Nagasaki University, 2. Centre de Recherches Medicales de Lambarene, 3. Institute for Tropical Medicine, University of Tubingen, 4. Universite des Sciences de la Sante de Libreville, 5. Medical University of Vienna, 6. National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, 7. Graduate School of Biomedical Sciences, Nagasaki University)

[P-HP-03]RARRES3 mediates interferon regulatory factor 1-induced suppression of hepatitis A virus replication through modulation of the mTOR activity

*Daisuke Yamane1, Asuka Hirai-Yuki2, Michinori Kohara1, Stanley Lemon3 (1. Tokyo Metropolitan Institute of Medical Science, 2. National Institute of Infectious Diseases, 3. University of North Carolina at Chapel Hill)

[P-HP-04]Establishment of Hepatitis B virus infection system by three-dimensional co-culture model of stellate cells and hepatocytes

*Misao Himeno1, Yuta Koui1, Shin-Wei Chen1, Hironori Nishitsuji2, Masaya Sugiyama2, Masashi Mizokami2, Taketomo Kido1, Atsushi Miyajima1 (1. University of Tokyo, Institute for Quantitative Biosciences, 2. National Center for Global Health and Medicine, The Research Center for Hepatitis and Immunology Department of Liver Diseases)

[P-HP-05]Analysis of intracellular hepatitis B virus dynamics based on a cell culture infection data and a mathematical model

*Senko Tsukuda1,2, Tatsuya Kurusu3, Kojima Soichi2, Masamichi Muramatsu1, Shingo Iwami3, Koichi Watashi1 (1. National Institute of Infectious Diseases, 2. RIKEN, 3. Kyushu University)

[P-HP-06]Screening for novel anti-HBV Kampos

*Md. Arifur Rahman1, Keiji Ueda1, Tomoyuki Honda1 (1. Osaka University Graduate School of Medicine)

[P-HP-07]Screening of new anti-HBV drug

*Rika Matsuyama1, Midori Takeda1, Masanori Ikeda1 (1. Division of Biological information Technology, Joint Research Center for Human Retrovirus Infection, Kagoshima University)

[P-HP-08]Development of HBV episomal DNA inhibitors derived from mutant lentivirus screening

*Fumihiko TAKEUCHI1, Sotaro Ikeda1, Yuta Tsukamoto1,2, Ryota Ouda1,3, Makoto Hijikata1, Koichi Watashi4, Takaji Wakita4, Kazuaki Chayama5, Amane Kogure1, Hiroki Kato1,2, Takashi Fujita1 (1. Institute for Frontier Life and Medical Sciences, Kyoto University, 2. Institute of Cardiovascular Immunology, University Hospital Bonn, 3. Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 4. National Institute of Infectious Diseases, 5. Graduate School of Biomedical & Health Sciences, Hiroshima University)

[P-HP-09]Evaluation of novel NNRTI candidates against Hepatitis B virus

*Eriko Ohsaki1, Yadarat Suwanmanee1, Keiji Ueda1 (1. Osaka University Graduate School of Medicine)

[P-HP-10]The HBV polymerase TP-RT domain and human HBV epsilon RNA binding inhibitor screening by the new vitro assay screening system.

*Xiao Quan liu1, Eriko Ohsaki1, Keiji Ueda1 (1. osaka university)

[P-HP-11]Identification of hepatitis B virus (HBV) replication inhibitors using HBV reverse transcriptase elongation reaction system

*Shogo Nakajima1,2, Koichi Watashi1,2, Kento Fukano1, Senko Tsukuda1,3, Hideki Aizaki1, Masamichi Muramatsu1, Takaji Wakita1, Tetsuya Toyoda4 (1. Department of Virology II, National Institute of Infectious Diseases, 2. Tokyo University of Science Graduate School of Science and Technology, 3. Liver Cancer Prevention Research Unit, Center for Integrative Medical Sciences, RIKEN, 4. Choju Medical Institute, Fukushimura Hospital)

[P-HP-12]4,4'-bis(cyclohexylmethyl)biphenyl-2,2',5,5'-tetraol is the novel anti-HBV compound targeting the viral core promoter.

*Atsuya Yamashita1, Tomohisa Tanaka1, Teruhime Otoguro1, Hirotake Kasai1, Kohji Moriishi1 (1. Department of Microbiology, Division of Medical Sciences, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi)

[P-HP-13]Development of cellular biosensors with customizable output for hepatitis B virus

*Satoko Matsunaga1, Jeremiah Stanley1, Kei Miyakawa1, Hironori Nishitsuji2, Koichi Watashi3, Kunitada Shimotohno2, Takaji Wakita3, Akihide Ryo1 (1. Yokohama-city university, 2. National Center for Global Health and Medicine, 3. National Institute of Infectious Diseases)

[P-HP-14]Construction of genomic and transcriptomic database of the tree shrew (Tupaia belangeri), which is a small animal model of HBV infection

*Takahiro Sanada1, Kyoko Kohara2, Tadasu Shin-I3, Naoki yamamoto1, Mohammad Enamul Hoque Kayesh2, Michinori Kohara1 (1. Tokyo Metropolitan Institute of Medical Science, 2. Kagoshima University, 3. BITS Co., Ltd.)

[P-HP-15]Pin1-dependent prolyl-isomerization regulates the stability of Hepatitis B virus core protein

*Kei Miyakawa1, Mayuko Nishi1, Satoko Matsunaga1, Koichi Watashi2, Takaji Wakita2, Akihide Ryo1 (1. Department of Microbiology, Yokohama City University School of Medicine, 2. Department of Virology II, National Institute of Infectious Diseases)

[P-HP-16]The nucleotide-binding domain of GRP78/BiP/HSPA5 interacts with the pre-S2 domain of Hepatitis B virus (HBV) and is involved in the HBV life cycle

*Yadarat Suwanmanee1, Keiji Ueda1 (1. Division of Virology, Department of Microbiology and Immunology, Osaka university Graduate School of medicine)

[P-HP-17]Abnormal hepatocellular organelles are still present in patients with sustained virological response (SVR)

*Haruyo Aoyagi1, Hiroko Iijima2, Minami Kikuchi1, Maiko Koyama3, Mami Matsuda1, Koichi Watashi 1, Ryosuke Suzuki1, Takahiro Masaki 4,1, Takeshi Saito7, Noritomo Shimada 5, Keizo Kato6, Masaru Enomoto 9, Kazuhiko Hayashi8, Akihito Tsubota4, Ayako Mimata 10, Yuriko Sakamaki 10, Shizuko Ichinose 11, Masamichi Muramatsu1, Kenjiro Wake12, Takaji Wakita1, Hideki Aizaki1 (1. National Institute of Infectious Diseases, Tokyo, 2. Hyogo College of Medicine, Hyogo, 3. Biomaster, Inc., Kanagawa, 4. The Jikei University School of Medicine, Tokyo, 5. Ootakanomori Hospital, Chiba, 6. hinmatsudo Central General Hospital, Chiba, 7. University of Southern California, Los Angeles, 8. Meijo Hospital, Aichi, 9. Osaka City University Graduate School of Medicine, Osaka, 10. Tokyo Medical and Dent al University, Tokyo, 11. Nippon Medical School hospital, Tokyo, 12. Minophagen Pharmaceutical Co., Ltd., Tokyo)

[P-HP-18]Screening of anti-hepatitis C virus natural compounds extracted from crude drugs

*XIN ZHENG1,3, YI YAN3, KOUSHO WAKAE1, NORIYUKI WATANABE1, ALY H. HUSSEIN1, KOICHI WATASHI1, RYOSUKE SUZUKI1, HIDEKI AIZAKI1, TAKAJI WAKITA1, SHAOJIANG SONG2, MASAMICHI MURAMASTU1 (1. National Institute of Infectious Diseases, VirologyⅡ, 2. Shenyang Pharmaceutical University, 3. Guangzhou Medical University)

[P-HP-19]Antiviral Activity of Steroidal Cardiac Glycosides Obtained from Dried Toad Cake against Hepatitis C Virus

*Hak Hotta1,2, Chie Aoki Utsubo2, Sachiko Nishimoto1, Hiroyuki Fuchino3, Nobuo Kawahara3, Ryo Masui4, Chishio Sugimoto4, Yasuharu Shimizu4, Kei-ichi Sudo4 (1. Konan Women's University, 2. Kobe University, 3. National Institutes of Biomedical Innovation, Health and Nutrition, 4. Kyushin Pharmaceutical Co., Ltd.)

[P-HP-20]Establishment of neutralizing E2 antibody from E2-immunized mouse

Minami Yoshida1,2, *NORIYUKI WATANABE2, Hussein Hassan Aly2, Madoka Koyanagi1, Yutaka Arimura1, Hideki Aizaki2, Masamichi Muramatsu2, Takaji Wakita2 (1. Department of Applied Life Science, Nippon Veterinary and Life Science University, 2. National Institute of Infectious Diseases)

[P-HP-21]Generation of human-rat chimeric anti-occludin monoclonal antibodies that strongly inhibit hepatitis C virus infection.

*Takeru Suzuki1,2, Yoshimi Shimizu1,3, Yoshitaka Shirasago1, Kohei Yoneda4, Minoru Tada5, Akiko Ishii5, Kazuo Sugiyama6, Tetsuro Suzuki7, Takaji Wakita8, Kiyohito Yagi4, Masuo Kondoh4, Masayoshi Fukasawa1 (1. Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 2. Department of Biological Sciense and Technology, Tokyo University of Science, 3. Department of Pharmaceutical Sciences, Teikyo Heisei University, 4. Graduate School of Pharmaceutical Sciences, Osaka University, 5. Division of Biological Chemistry and Biologicals, National Institutes of Health Science, 6. Gyotoku General Hospital, 7. Department of Infectious Diseases, Hamamatsu University School of Medicine, 8. Department of Virology II, National Institute of Infectious Diseases)

[P-HP-22]Effect of hepatitis C virus infection on phospholipid composition in host cells.

*Hirotake Kasai1, Tomohisa Tanaka1, Atsuya Yamashita1, Teruhime Otoguro1, Kohji Moriishi1 (1. University of Yamanashi)

[P-HP-23]Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Diacylglycerol O-acyltransferase 1 (DGAT1) via Chaperone-mediated Autophagy

*Putu Yuliandari1, Chieko Matsui1, Lin Deng1, Takayuki Abe1, Ikuo Shoji1 (1. Graduate School of Medicine, Kobe University)

[P-HP-24]A chlorophyll derivative, methyl-pheophorbide A inhibits hepatitis C virus assembly by affecting apolipoprotein production

*Chie Aoki Utsubo1, Hak Hotta2 (1. Kobe University Graduate School of Health Sciences, 2. Konan Women's University)

[P-HP-25]Mechanistic analysis of HBV reactivation by DAAs for HCV

*Takuya Yamamoto1, Chikako Ono1, Shiho Torii1, Takuma Izumi1, Asuka Sato1, Yuzy Fauzyah1, Yuhei Morioka1, Takasuke Fukuhara1, Yoshiharu Matsuura1 (1. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University)

[P-HP-26]Foodborne Risks Caused by Hepatitis E Virus Distribution in Pigs in Vietnam

*Katsuro Hagiwara1, Yukari Kezuka1, Vuong Bui Nghia2, Hu Suk Lee3, Hung Nguyen Viet3, Kohei Makita1 (1. School of Veterinary Medicine, Rakuno Gakuen University, 2. National Institute of Veterinary Research, Vietnam, 3. International Livestock Research Institute, Vietnam)

[P-HP-27]Production of hepatitis E virus (genotypes 3 and 4) ORF2 proteins in E. coli and assembling into virus-like particles for the development of hepatitis E vaccines

*Tominari Kobayashi1, Masaharu Takahashi1, Shigeo Nagashima1, Takashi Nishiyama1, Putu Prathiwi Primadharsini1, Tsutomu Nishizawa1, Hiroaki Okamoto1 (1. Jichi Medical University)

[P-HP-28]The tight junction protein ZO-1 is necessary for growth of hepatitis E virus in cultured cells

*Shigeo Nagashima1, Putu Prathiwi Primadharsini1, Tominari Kobayashi1, Masaharu Takahashi1, Hiroaki Okamoto1 (1. Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine)